Institute of Good Manufacturing Practices India Global accredited training provider Registered under the Societies Registration Act,1860, Government of India An ISO 9001:2008 Certified Organisation Permanently empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh Conferred with QUALITY COUNCIL OF INDIA (QCI) – D.L. SHAH NATIONAL QUALITY AWARD – Certificate of Merit 2015 New Delhi | Noida | Hyderabad | Lucknow
Trusted by training participants in over 20 countries
The US Food and Drug Administration (USFDA) has issued a warning letter to Unimark Remedies for violating current good manufacturing practice norms at its plant near Ahmedabad in Gujarat. Unimark, a vertically integrated healthcare company, aims in developing affordable generic medicines in various therapeutic segments such as respiratory, cardiovascular, anti-infective, central nervous system for global markets.
"An inspector in March had found significant deviations from current good manufacturing practice for the manufacture of active pharmaceutical ingredients at the plant,” said the USFDA in a warning letter. The violations included failure of the company to document production and analytical testing activities as they are performed
